<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115817">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01676168</url>
  </required_header>
  <id_info>
    <org_study_id>201205098RIC</org_study_id>
    <nct_id>NCT01676168</nct_id>
  </id_info>
  <brief_title>To Study Gene Expression of Postburn Hypertrophic Scar</brief_title>
  <official_title>To Study Gene Expression of Postburn Hypertrophic Scar</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <authority>Taiwan: Department of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim: To compare the gene expression of postburn hypertrophic scar with normal skin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Postburn hypertrophic scar (HS) remains a challenging problem. Although varied
      clinical therapeutic methods have been used, none of them has been widely accepted as a
      standard care. As hypertrophic scar is hereditary, gene therapy can be a potential tool for
      scar treatment. To investigate the correlation between the clinical presentation of the
      hypertrophic scar and its gene expression, we propose an analysis of gene expression in the
      hypertrophic scar using DNA microarray and Real-Time Quantitative PCR. The study result may
      form the base of clinical treatment.

      Methods and Materials: Thirty scar patients requiring surgical treatment in NTUH burn center
      will be enrolled into the study. Inclusion criteria: (1) Age between 20 and 80 (2) Patients
      with postburn hypertrophic scar require surgical treatment.

        1. Hypertrophic scar and normal skin collection: Under Clinical Trial Informed Consent of
           Research Ethic Committee, scar and normal skin specimen of 1x1cm2 each will be
           collected and transported to tissue bank with a vacuum low temperature container. The
           specimen will be kept in a -80â„ƒ refrigerator.

        2. RNA extraction from skin tissue: The RNA extraction will be performed using kit
           available in the market. Spectrophotometer and gel electrophoresis will be used to
           measure the purity and concentration of RNA.

        3. Gene expression analysis: DNA microarray and Real-Time Quantitative PCR will be used to
           analyze RNA expression of hypertrophic scar and normal skin.

      Statistics: Student's t-test will be used to compare statistically gene expression between
      hypertrophic scar and normal skin. P &lt; 0.05 will be considered as statistical significance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cicatrix, Hypertrophic</condition>
  <arm_group>
    <arm_group_label>hypertrophic scar</arm_group_label>
    <description>1x1cm2 hypertrophic scar of post-burn patients are taked by visiting staff when they accept scar-reconstructive surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal skin</arm_group_label>
    <description>When the patient accept skin grafting surgery, visiting staff will take 1x1cm2 normal skin.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Hypertrophic scar from post-burn patient
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The patient have hypertrophic scar.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age20~80, hypertrophic scar patient

        Exclusion Criteria:

          -  no specific limitation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kean Eng Yeong, college</last_name>
    <role>Study Chair</role>
    <affiliation>NTUH Burn lab</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kean Eng Yeong, college</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>65648</phone_ext>
    <email>smartpace88@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kean Eng Yeong, college</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>65648</phone_ext>
      <email>smartpace88@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Kean Eng Yeong, College</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <lastchanged_date>August 28, 2012</lastchanged_date>
  <firstreceived_date>August 28, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cicatrix, Hypertrophic</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
